BioSpace News Archive

Terns Pharmaceuticals, Inc. announced that preclinical data supporting TERN-501, a highly selective thyroid hormone receptor beta receptor agonist, in combination with a GLP-1 receptor agonist for obesity will be highlighted in a poster presentation at the American Diabetes Association 84th Scientific Sessions, taking place June 21 – 24, 2024 in Orlando, FL.

Starton Therapeutics Inc. announced today positive interim top-line data from its low-dose lenalidomide STAR-LLD Phase 1b clinical trial in multiple myeloma (MM).

Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion.

IonQ (NYSE: IONQ), a leader in the quantum computing industry, recently announced the promotion of Dr. Dean Kassmann to Senior Vice President of IonQ’s newly formed Engineering and Technology division, following his tenure as Vice President of Engineering.

NX Development Corp. (NXDC) is pleased to announce a significant milestone.

Trenchant Technologies Capital Corp. (CSE: AITT) (OTC: AITTF) (“Trenchant” or the “Company”) announces that, further to its News Release of June 12, 2024, it has completed its non-brokered private placement financing (the “Offering”), pursuant to which it has issued 400,000 units (each, a “Unit”) for gross proceeds of $100,000.